PTGX

NASDAQStock$142.30+3.56 (+2.57%)
Mkt Cap 9.2BP/E —Div Yield —Beta 1.79Vol 510.6K
52W$65.30
$158.62

ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)

1M

-2.49%

3M

+3.39%

6M

+44.00%

YTD

+63.23%

1Y

+117.35%

3Y

+761.38%

5Y

+680.15%

ETFs That Hold PTGX

Protagonist Therapeutics, Inc. is held by 144 ETFs. The largest position by market value is in IWM (iShares Russell 2000 ETF).

ETFFund NameWeight
IJTiShares S&P Small-Cap 600 Growth ETF1.11%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.00%
SMMViShares MSCI USA Small-Cap Min Vol Factor ETF0.00%
XJRiShares ESG Select Screened S&P Small-Cap ETF0.00%

Excludes leveraged and inverse ETFs.

PreviousPage 8 of 8

Frequently Asked Questions

How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 144 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IWM (iShares Russell 2000 ETF).
What is the largest ETF that holds PTGX?
By fund size, IWM (iShares Russell 2000 ETF) with $77.54B in AUM holds 0.29% of its portfolio in PTGX, representing $227.2M in market value.
What percentage of PSCH is PTGX?
PTGX makes up 4.93% of PSCH (Invesco S&P SmallCap Health Care ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.